Big Pharma

Big Pharma Profits by Keeping Us Sick: The Truth Behind Chronic Treatments

Pharmaceutical companies operate on business models that emphasize continuous revenue streams, particularly through the treatment of chronic conditions like diabetes, hypertension, and high cholesterol. This approach contrasts sharply with the one-time profit from a cure. While treatments for diseases such as HIV and cancer generate ongoing revenue, the development and prioritization of cures face numerous economic and regulatory hurdles. Critics argue that Big Pharma’s focus on profit leads to the suppression of potential cures, and regulatory bodies and market control entities, like LegitScript, often act to maintain this status quo. This article examines the inherent economic incentives in the pharmaceutical industry that prioritize treatments over cures, the suppression of natural remedies, and the broader implications for global health.

Read more

LegitScript’s Influence: More Harm Than Good?

LegitScript, a private company with significant control over major tech and payment companies, influences what medications Americans can access and purchase online. This control supports big pharmaceutical companies by blocking affordable Indian generics, maintaining high drug prices. This article argues that such overreach undermines public health and calls for greater transparency and legislative intervention to ensure Americans have access to safe and affordable medications.

Read more

Future at a Crossroads: The Escalating Cost of Living and Healthcare in America

As the trajectory of America’s economic and healthcare landscape points towards rising healthcare costs, corporate monopolization of essential services, and stagnant wage growth, the future appears daunting. A family of four may soon need to earn $200,000 annually by 2034 just to manage healthcare expenses. This article explores the systemic issues leading to these trends and their impact on daily living, emphasizing the need for significant policy changes to prevent an unsustainable future dominated by financial burdens and health disparities. The influence of big pharmaceutical companies, the monopolization of food production, and the socio-economic challenges faced by lower-income communities highlight the urgent need for reforms in healthcare and economic policies.

Read more

The Corporate Cabal: Unveiling America’s Controlled Future

As America’s democracy faces the overwhelming influence of corporate conglomerates, a troubling future emerges where food and health are tightly controlled by a few powerful entities. This article explores the intricate connections between corporations, government bodies, and public health systems, revealing a reality where corporate interests overshadow public policy. With major corporations like Monsanto and Bayer dominating the food supply and pharmaceutical giants dictating drug availability and pricing, the lines between public health and corporate profit blur. The role of the FDA and political entities, swayed by substantial campaign contributions, further complicates the landscape. This scenario paints a future where basic needs are commodified, healthcare becomes increasingly inaccessible, and technological advancements facilitate unprecedented surveillance and control. However, grassroots movements and public advocacy offer hope for reclaiming transparency and fairness in the system.

Read more

Beyond the Patents: The Monopoly Practices of Big Pharma and What American Consumers Aren’t Told

The high cost of prescription drugs in the U.S. is driven by Big Pharma’s patent practices and strategic blocking of affordable generic medications, especially from India. This article reveals how evergreening tactics, intense lobbying, and restrictive FDA regulations keep drug prices artificially high and prevent the entry of cheaper alternatives. These monopoly practices significantly impact consumers, leading to high healthcare costs and limited access to essential medications. Organizations like Ashvin Medicara play a crucial role in advocating for the importation of safe and affordable generics, challenging the power of Big Pharma and supporting policy changes for better healthcare access.

Read more

Healthcare and Control: The Corporate Takeover of America

In the shadows of America’s sprawling metropolises and through the silent bytes of digital communication, a more sinister vision of the future is being forged—one where the illusion of freedom masks an unsettling reality. This article exposes how an elite cabal of corporations and their billionaire figureheads are orchestrating a future where they hold unchallenged dominion over every facet of American life, from our healthcare and food supply to our economic stability and personal liberties. These corporate overlords seek to monopolize health services, turning basic healthcare into a luxury item only the wealthy can afford, while digital surveillance grants them unprecedented control over personal data. Political leaders, seduced by corporate donations, become mere puppets ensuring laws protect these monopolies. This orchestrated control aims to create a dependent society, where true freedom becomes a relic of the past. Recognizing and challenging these forces is crucial to reclaiming the essence of American life and liberty.

Read more

Big Pharma’s Best Friend: The FDA Exposed

The Food and Drug Administration (FDA), once a trusted guardian of public health, now faces criticism for its close ties with Big Pharma, earning nicknames like “Federal Deceit Advocates” and “Federal Drug Atrocities.” This article examines the FDA’s failures, its revolving door with the pharmaceutical industry, and how corporate protectionism has overshadowed public health. With high-profile drug approval failures like the opioid crisis and Vioxx scandal, and financial dependency on pharmaceutical user fees, the FDA’s actions often prioritize corporate profits over public welfare. To restore trust and integrity, significant reforms are necessary, focusing on reducing conflicts of interest and increasing transparency.

Read more

How Big Pharma, the FDA, Congress, and Shadow Organizations Violate Our Constitutional Rights to Healthcare

The American healthcare system is often lauded as one of the most advanced in the world, but beneath the surface lies a troubling reality of collusion involving Big Pharma, the FDA, Congress, and shadow organizations like LegitScript. These entities, created to protect public health, prioritize corporate profits over individual rights and access to affordable healthcare. This article exposes how these powerful groups manipulate regulations, lobby against public interests, and violate our constitutional rights to make healthcare choices. Through financial power, regulatory influence, and digital censorship, they maintain high drug prices and limit access to affordable medications. Reform is urgently needed to ensure transparency, accountability, and a healthcare system that serves the needs of the people.

Read more

Healthcare Tyranny: The Stranglehold of Big Pharma and Government Overreach

In the U.S., an alarming alliance between big pharma, congressional elites, and government agencies is transforming healthcare into a system of control and oppression. Through extensive lobbying and financial contributions, big pharma has captured the legislative process, ensuring healthcare policies prioritize profit margins over patient well-being. Government agencies like the FDA enforce monopolistic practices, restricting access to affordable medications. This article explores the dire consequences of this collusion and calls for reclaiming healthcare freedom by breaking monopolies and expanding access to affordable medications from trusted international sources.

Read more

Undermining the Foundations: How Big Pharma and U.S. Politicians Contradict American Ideals

In the U.S., the foundational principles of freedom, equality, and the pursuit of happiness are undermined by the collusion between big pharma, congressional elites, and government agencies. This alliance prioritizes profit over patient welfare, restricting access to affordable medications and violating constitutional promises of life and liberty. To realign with American ideals, there must be reforms to limit pharmaceutical influence, promote competition, and prioritize patient-centric policies. It’s crucial to advocate for a healthcare system that truly serves its people and reflects the nation’s founding values.

Read more